insights_auto
Why is SABS down 4,81%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,77 $
arrow_downward
-4,81%(-0,14) 1D
20 қар., 09:41:23 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 $
High
2,83 $
Low
2,76 $
Mkt. cap
249,55 млн
Avg. vol.
709,90 м.
Volume
1,01 мың
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
2,79 $
High
2,83 $
Low
2,76 $
Mkt. cap
249,55 млн
Avg. vol.
709,90 м.
Volume
1,01 мың
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
ChartMill
·
1 сағат бұрын
S&P 500 Premarket Movers Friday: Gainers and Losers
Coinpaper
·
3 минут бұрын
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
Reuters
·
34 минут бұрын
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
46 минут бұрын
Ryan Detrick: S&P 500 posts six-day losing streak, longest since April 2024
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Флорида, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitesab.bio